Chronic Ischaemic Heart Disease, Depressive Episode, Hypertension
Conditions
Keywords
Depressive episode, Chronic ischaemic heart disease, Hypertension
Brief summary
Out-patients with coronary heart disease or hypertension will fill out a depression screening questionnaire while waiting in a cardiac clinic. Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment. Patients in the control group receive no direct screening-feedback but their cardiologist will be informed about the screening result. All patients with a positive screening-result will be contacted after one month and six months and asked for symptoms of depression, and their use of health care. The aim of this study is to evaluate the efficiency of this minimal intervention on the course of depressive symptom in patients with known coronary heart disease or hypertension.
Detailed description
The aim of this study is to evaluate the efficiency of a minimal intervention on the course of depressive symptoms in patients with known coronary heart disease (CHD) or hypertension. By means of a depression screening and individual patient-targeted feedback the level of depression should decrease, the percentage of treated depressed patients should increase and health economic costs should be lowered. The main hypothesis is that screening plus targeted feedback results in a greater reduction of depression than screening only.
Interventions
Using a randomised-controlled study design half of the patients will receive a patient-targeted written screening feedback. This feedback contains information about depression in general, depression-severity adapted treatment guidelines and contact-information for treatment.
Sponsors
German Federal Ministry of Education and Research
Universitätsklinikum Hamburg-Eppendorf
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SCREENING
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Gender: Both, male and female * Minimum Age: 18 Years * Maximum Age: no maximum age * Attendance in a cardiac clinic; * Clinical diagnosis of coronary heart disease or hypertension; * Age ≥ 18 years; * Sufficient language skills; * Informed consent
Exclusion criteria
* Life threatening health status; * Severe somatic or/and psychological disorder that needs urgent treatment; * Acute suicidal tendency; * Severe cognitive or/and visual difficulties; * Not being able to fill out questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of depression one month after screening (Patient Health Questionnaire-9) | One month after depression screening |
Secondary
| Measure | Time frame |
|---|---|
| Level of depression six months after screening (Patient Health Questionnaire-9) | One month and six months after screening |
| Proportion of patients treated for depression. | One month and six months after screening |
| Direct and indirect health costs | One month and six months after screening |
| Quality-adjusted years of life and quality of life (EuroQol-5D) | One month and six months after screening |
Countries
Germany
Outcome results
None listed